A new study led by researchers from the CUNY Institute for Implementation Science in Population Health (ISPH) finds that the 2025 freeze on U.S. foreign assistance triggered disruptions to HIV ...

In 2006, Gilead Sciences and Bristol Myers Squibb left a permanent mark on the HIV treatment paradigm by fusing together three antiretrovirals and creating the ...

Young girls and boys were urged to seek guidance, ask questions, and use the available health services at Rabie Ridge Clinic ...

Kenya takes a massive leap in HIV prevention, here is everything you need to know about the Lenacapavir rollout.

Lenacapavir is administered twice a year and is designed to provide sustained protection against HIV infection.

By pairing digital tools with tailored HIV services delivered by community health workers and clinicians, a study has reduced new HIV cases by 70% in rural Kenya and Uganda. This successful strategic ...

Doxy-PEP reshapes STI prevention, while congenital syphilis surges; experts urge scaling HIV and STI care infrastructure to ...

Executive actions in 2025 produced a 90-day freeze and stop orders; waivers incompletely restored services, with notable gaps in PrEP access for nonpregnant, nonbreastfeeding individuals. New research ...

Dar es Salaam. Tanzania has officially registered Lenacapavir, a long-acting injectable drug for the prevention and control of HIV, marking what officials describe as a significant milestone in the ...

Patients with HIV showed lower cases of steatotic liver disease when switched to ViiV Healthcare’s Dovato compared to Biktarvy.

Kenya is set to begin the national rollout of the long-acting HIV prevention injection, Lenacapavir, on Thursday, February 26, 2026. However, not everyone at risk will qualify. The Programs Officer, ...

Lawmakers in Georgia, the state with the highest rate of new HIV infections in the country, are moving to allow pharmacists to prescribe and administer HIV prevention drugs.